Next, we evaluated the relapse-free survival time (RFS) in PCa patients expressing high or low ACAT1, OXCT1, BDH1, HMGCL, HMGCS2, SLC16A1 and SLC16A7. Results demonstrated significant association of high ACAT1 and OXCT1 expression with shorter RFS (Fig. 6C). This evidence concerns the gene OXCT1 and posterior cortical atrophy.